This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_ANUS_ANALCANAL_EXALLC for full statistics.
Malignant neoplasm of anus and anal canal
C3_ANUS_ANALCANAL
anal neoplasm: A benign or malignant neoplasm that affects the anal canal or anal margin. Representative examples of benign neoplasms include squamous papilloma and papillary hidradenoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and melanoma.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
157 |
4. Check minimum number of eventsNone |
157 |
5. Include endpointsNone |
157 |
6. Filter based on genotype QC (FinnGen only) |
157 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of anus and anal canal
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 157 | 96 | 61 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 64.77 | 62.45 | 68.42 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 145
- Matched controls
- 1449
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C21.1
ICD-10 Finland
Malignant neoplasm: Anal canal
+∞
120.0
98
*
C21.0
ICD-10 Finland
Malignant neoplasm: Anus, unspecified
+∞
90.2
77
*
8070/3-C21.0
ICD-O-3
Squamous cell carcinoma, NOS, of anus, NOS
+∞
63.2
56
*
130
Kela drug reimbursment
Malignant tumour
25.8
50.0
74
56
WF002
NOMESCO Finland
Radical radiotherapy
40.6
49.2
62
26
8070/3-C21.1
ICD-O-3
Squamous cell carcinoma, NOS, of anal canal
+∞
48.7
44
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
20.3
46.9
77
76
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
61.2
45.4
52
13
UJH02
NOMESCO Finland
Anoscopy
26.8
40.3
57
34
A03FA01
ATC
metoclopramide; systemic, rectal
11.2
38.1
95
209
C21.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal
+∞
33.6
31
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
46.1
31.5
38
11
JG1CG
NOMESCO Finland
Extensive MRI of rectum
135.5
31.1
32
*
L01BC06
ATC
capecitabine; oral
29.5
30.4
41
19
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
179.4
28.8
29
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
46.8
27.6
33
9
N02AA05
ATC
oxycodone; systemic
8.3
25.6
67
136
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
243.2
21.2
21
*
JN4BD
NOMESCO Finland
Extensive body CT
7.6
19.7
51
96
JG1BG
NOMESCO Finland
MRI of rectum
64.2
19.5
22
*
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
45.0
19.2
23
6
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
11.9
19.1
36
39
JHA10
NOMESCO Finland
Biopsy of anal canal
216.6
19.0
19
*
UJG02
NOMESCO Finland
Proctoscopy
26.0
19.0
26
12
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
48.6
17.8
21
5
JHA00
NOMESCO Finland
Anal or perianal incision
57.4
17.5
20
*
UJF32
NOMESCO Finland
Coloscopy
4.7
16.8
78
285
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
+∞
15.9
15
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
13.0
15.8
28
26
A04AA02
ATC
granisetron; systemic, transdermal
9.5
15.2
32
42
ZX095
NOMESCO Finland
Combined chemoradiotherapy
89.3
14.9
16
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
165.8
14.7
15
*
A04AA01
ATC
ondansetron; systemic, rectal
9.9
14.7
30
37
ZX070
NOMESCO Finland
Intensity modified radiotherapy
22.9
14.2
20
10
JHA20
NOMESCO Finland
Excision of lesion of anal canal or perianal tissue
31.7
13.3
17
6
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
12.1
11.7
21
20
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
+∞
11.6
11
*
D75
ICPC
Malignant neoplasm colon/rectum
47.2
11.1
13
*
WF001
NOMESCO Finland
Preoperative radiotherapy
64.8
10.8
12
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
35.4
10.5
13
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.2
10.2
33
78
ZX090
NOMESCO Finland
Other technic of radiotherapy
10.6
9.6
18
19
C21.2
ICD-10 Finland
Malignant neoplasm: Cloacogenic zone
+∞
9.5
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
7.2
9.2
22
35
WW500
NOMESCO Finland
Blood transfusion
9.6
9.1
18
21
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.3
8.7
23
42
8140/3-C21.1
ICD-O-3
Adenocarcinoma, NOS, of anal canal
+∞
8.4
8
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.3
8.4
32
89
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
18.5
8.2
12
7
Z93.3
ICD-10 Finland
Colostomy status
35.5
8.2
10
*
ULA02
NOMESCO Finland
Kolposcopy
4.7
7.9
27
67
Z51.5
ICD-10 Finland
Palliative care
5.5
7.9
23
48
C20
ICD-10 Finland
Malignant neoplasm of rectum
26.6
7.7
10
*
P01AB01
ATC
metronidazole; oral, rectal
2.7
7.6
78
436
JG1DG
NOMESCO Finland
Very extensive MRI of rectum
84.1
7.5
8
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
84.1
7.5
8
*
JGB36
NOMESCO Finland
Wide excision of rectum
84.1
7.5
8
*
JN4AD
NOMESCO Finland
Body CT examination
4.6
7.3
25
62
JF1CM
NOMESCO Finland
Small bowel extensive MRI with with high intensity magnet
+∞
7.3
7
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
31.7
7.2
9
*
JFF23
NOMESCO Finland
Transversostomy
31.7
7.2
9
*
H02AB02
ATC
dexamethasone; systemic
3.7
7.0
31
98
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.0
7.0
14
17
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
8.5
6.8
14
18
ZXD10
NOMESCO Finland
Scheduled procedure
2.6
6.8
72
402
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
6.7
30
96
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
10.8
6.7
12
12
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
6.5
61
318
WX600
NOMESCO Finland
Single shot through catheter
19.0
6.3
9
5
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.6
6.3
28
89
R50.9
ICD-10 Finland
Fever, unspecified
3.3
6.3
34
124
JG1CM
NOMESCO Finland
Extensive MRI of rectum (more than 1.5 T)
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
8.3
6.3
13
17
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
6.6
6.2
15
25
D18
ICPC
Change in faeces/bowel movements
13.3
6.2
10
8
Z2221
NOMESCO Finland
Medical doctor
2.7
6.2
50
239
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
10.7
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
95
181
11.76
55.89
4.8
4.4
ug/l
5.0
69.0
0.85
76
152
(3022145) Colonoscopy Study observation
61
168
5.30
21.92
2.7
1.2
—
—
—
0
0
(4035726)
52
129
5.53
21.00
1.4
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
83
368
3.66
14.58
7.7
4.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
121
731
3.86
12.24
16.9
9.7
e9/l
3.7
4.1
0.84
106
642
(3015377) Calcium [Moles/volume] in Serum or Plasma
91
469
3.24
11.84
7.8
3.6
mmol/l
2.4
2.4
0.64
82
414
(40768804) Tissue Pathology biopsy report
97
523
3.24
11.60
3.2
2.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
43
141
3.82
11.57
2.1
1.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
70
332
3.00
10.17
6.6
3.7
%
92.7
90.2
0.31
70
326
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
64
296
2.96
9.64
2.4
2.0
mg/l
3.3
3.3
0.00
48
251
(3042936) Bacteria identified in Isolate by Culture
50
201
3.18
9.63
2.8
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
69
335
2.89
9.48
11.5
7.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
41
153
3.27
8.87
2.3
2.5
umol/l
12.1
9.5
0.15
32
134
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
63
308
2.75
8.35
5.2
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
30
97
3.59
8.07
2.2
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
21
54
4.33
7.72
2.0
1.6
ug/l
6.1
6.8
0.04
21
49
(3044640) Blood type and Crossmatch panel - Blood
74
408
2.54
7.52
5.2
2.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
98
618
2.56
7.44
11.2
5.6
mmol/l
1.2
1.2
0.57
90
557
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
96
604
2.52
7.26
7.2
3.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
92
568
2.50
7.24
10.0
8.9
inr
1.4
1.3
0.26
20
165
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
101
665
2.45
6.70
12.7
6.6
mmol/l
1.2
1.2
0.74
89
563
(3018010) Neutrophils/100 leukocytes in Blood
90
580
2.29
6.04
6.1
5.7
%
58.9
57.5
0.49
83
537
(3019069) Monocytes/100 leukocytes in Blood
89
575
2.26
5.89
7.0
6.0
%
9.4
8.6
1.01
82
532
(3021960) Folate [Moles/volume] in Serum or Plasma
59
322
2.33
5.84
1.5
1.6
nmol/l
19.0
21.6
0.52
49
262
(3002030) Lymphocytes/100 leukocytes in Blood
90
586
2.26
5.82
6.8
5.9
%
23.3
27.2
2.10
82
535
(3022096) Basophils/100 leukocytes in Blood
86
554
2.22
5.66
6.8
5.6
%
0.7
0.7
0.07
79
508
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
43
210
2.44
5.41
3.6
3.1
e6/l
1.2
1.8
0.54
26
115
(3018418) pH of Serum or Plasma
69
414
2.19
5.34
6.6
4.0
ph
7.4
7.4
0.64
11
77
(3006504) Eosinophils/100 leukocytes in Blood
87
572
2.17
5.34
6.8
5.7
%
2.7
2.8
0.11
81
528
(3002256) Pathology report gross observation
36
164
2.55
5.23
1.2
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
30
129
2.64
4.88
2.7
2.2
u/l
31.6
28.7
0.27
25
104
(42870588) Differential panel, method unspecified - Blood
66
404
2.09
4.73
7.4
5.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
70
3.13
4.69
21.3
8.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
31
140
2.51
4.56
1.8
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
44
235
2.21
4.43
3.1
2.8
e6/l
1.1
0.8
0.15
27
135
(3002582) Erythrocytes [#/volume] in Urine
66
416
2.01
4.28
5.2
3.2
e6/l
17.2
207.6
0.68
54
328
(3027945) Reticulocytes/100 erythrocytes in Blood
32
151
2.41
4.28
1.8
3.5
%
1.8
1.8
0.03
26
136
(3001604) Monocytes [#/volume] in Blood
88
615
1.98
4.23
6.9
5.7
e9/l
0.6
0.6
0.46
67
531
(3027801) Oxygen [Partial pressure] in Arterial blood
33
159
2.36
4.21
14.4
6.7
kpa
12.3
11.6
0.47
33
152
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
33
159
2.36
4.21
14.5
6.7
kpa
5.2
5.1
0.58
33
152
(3006315) Basophils [#/volume] in Blood
88
617
1.97
4.17
6.9
5.7
e9/l
0.0
0.0
0.23
67
533
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
79
536
1.95
4.11
2.1
2.0
pmol/l
84.4
95.4
1.30
43
261
(3037467) Urinalysis macro (dipstick) panel - Urine
116
901
2.10
4.05
6.3
4.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
90
641
1.95
4.02
7.5
6.0
e9/l
0.2
0.2
0.20
69
566
(3003694) ABO and Rh group [Type] in Blood
54
323
2.02
4.01
1.4
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
40
215
2.15
3.93
2.5
1.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
19
72
2.86
3.90
2.1
1.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
88
628
1.91
3.85
7.0
5.8
e9/l
1.5
1.8
1.29
68
563
(3026008) Bacteria identified in Urine by Culture
65
421
1.93
3.81
4.9
2.9
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
6
5
12.40
3.79
3.7
2.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
153
2.28
3.73
2.2
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
73
495
1.89
3.70
6.0
3.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
24
106
2.49
3.68
1.8
3.8
e9/l
60.8
71.5
0.90
15
81
(3001122) Ferritin [Mass/volume] in Serum or Plasma
75
515
1.87
3.64
3.4
2.7
ug/l
236.2
123.5
1.40
70
468
(3018095) Leukocytes [#/volume] in Urine
72
488
1.88
3.64
6.4
3.9
e6/l
38.5
74.1
0.68
55
354
(3030467) Casts [#/volume] in Urine by Automated count
60
384
1.91
3.61
5.1
3.1
e6/l
0.4
0.4
0.12
48
288
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
9
8.07
3.59
2.6
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
58
371
1.89
3.47
5.0
3.0
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
20
83
2.62
3.47
19.4
8.6
%
92.2
94.5
0.30
20
83
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
30
155
2.16
3.22
2.2
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
23
109
2.30
3.03
23.1
7.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
27
139
2.14
2.92
3.3
4.8
u/l
225.4
246.9
0.26
27
132
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
36
3.21
2.87
1.7
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
36
209
1.94
2.82
2.5
1.9
s
30.2
29.3
0.32
36
201
(3012544) pH of Venous blood
25
131
2.08
2.59
7.7
3.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
24
124
2.10
2.57
7.6
3.5
mmol/l
2.2
2.1
0.08
18
99
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
16
4.53
2.50
1.3
1.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
16
71
2.40
2.44
12.3
6.1
mmol/l
24.2
24.9
0.40
16
71
(3017143) Hepatitis C virus Ab [Presence] in Serum
21
106
2.13
2.39
2.1
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
45
295
1.74
2.37
2.0
1.7
mg/l
1.1
1.2
0.10
35
238
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
6
13
4.75
2.29
2.2
1.3
u/l
58.8
52.5
—
6
8
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
9
5.69
2.23
1.0
2.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
31
3.02
2.11
2.8
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
24
134
1.93
2.10
6.3
3.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
70
2.26
2.06
1.3
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
21
3.44
1.99
2.3
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
39
2.67
1.96
1.6
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
46
2.50
1.90
2.6
2.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
29
2.85
1.82
11.0
2.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
36
2.59
1.77
1.2
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
18
3.42
1.76
12.8
1.6
%
52.8
55.0
—
6
18
(1761868) Lipid panel - Serum or Plasma
27
411
0.59
1.75
3.3
3.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
30
2.75
1.75
1.0
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
30
2.75
1.75
1.0
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
112
1252
0.63
1.74
4.6
4.8
mmol/l
1.5
1.5
0.56
102
1142
(3009542) Hematocrit [Volume Fraction] of Blood
126
1115
1.66
1.74
38.5
15.7
%
36.6
39.5
3.32
97
780
(3008898) HLA-B27 [Presence]
0
47
0.00
1.74
0.0
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
17
90
2.00
1.73
7.5
6.8
mmol/l
24.2
24.8
0.40
17
85
(3000494) Fungus identified in Specimen by Culture
27
168
1.73
1.69
1.3
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
108
1213
0.65
1.65
6.4
6.2
mmol/mol
40.5
40.3
0.05
96
1117
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
14
3.65
1.63
1.2
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
72
571
1.48
1.62
17.2
9.8
e9/l
0.0
0.0
0.99
50
470
(3004588) Protein electrophoresis panel - Serum or Plasma
18
100
1.90
1.61
1.4
3.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
20
3.08
1.59
1.7
1.7
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
33
2.50
1.56
1.1
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
13
65
2.09
1.53
12.5
3.3
mmol/l
25.2
24.1
0.62
13
58
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
21
2.93
1.52
1.5
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
16
3.19
1.45
1.4
2.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
138
1268
1.73
1.43
35.9
14.9
mg/l
31.2
23.8
2.08
126
1014
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
193
0.49
1.41
1.3
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
106
1.79
1.36
5.7
3.2
ml/min/173m2
58.8
60.8
—
8
42
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
67
538
1.43
1.36
2.7
2.4
nmol/l
72.1
77.8
1.08
57
469
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
69
1.96
1.33
1.7
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
37
267
1.50
1.29
3.4
3.4
ng/l
94.1
137.2
0.28
32
212
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
35
2.35
1.29
1.5
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
35
2.35
1.29
1.0
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
27
183
1.57
1.24
1.3
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
19
2.68
1.22
1.0
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
110
977
1.42
1.19
4.5
4.4
mm/h
27.0
13.0
6.07
102
887
(3014051) Protein [Presence] in Urine by Test strip
0
33
0.00
1.17
0.0
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
36
265
1.47
1.14
1.8
1.7
nmol/l
903.2
1169.6
1.41
27
200
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
116
1259
0.70
1.11
4.5
4.8
mmol/l
4.7
4.7
0.15
106
1159
(3027273) Bicarbonate [Moles/volume] in Venous blood
12
67
1.86
1.08
1.9
3.4
mmol/l
24.9
24.9
0.01
12
67
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
33
2.17
1.07
1.1
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
131
1211
1.49
1.06
33.4
14.1
ml/min/173m2
79.2
76.6
0.68
118
1003
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
46
2.01
1.05
2.6
1.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
17
107
1.66
1.05
2.6
2.0
ng/l
196.7
167.8
0.16
12
94
(42529406) Shigella sp [Presence] in Stool by Culture
9
48
1.93
1.02
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
48
1.93
1.02
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
48
1.93
1.02
1.1
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
120
1290
0.70
1.01
5.1
5.4
mmol/l
2.8
2.8
0.24
108
1174
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
61
1.86
1.01
1.3
2.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
117
1262
0.71
1.00
5.1
4.9
mmol/l
6.0
6.0
0.17
104
1148
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
111
1207
0.73
0.99
4.0
4.3
mmol/l
1.4
1.3
0.64
99
1095
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
23
2.21
0.98
1.2
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
17
110
1.61
0.95
4.0
3.3
%
0.3
0.9
—
8
35
(3002179) Metamyelocytes/100 leukocytes in Blood
15
94
1.66
0.94
3.8
3.2
%
0.8
0.5
—
5
21
(3044889) 12 lead EKG panel
105
944
1.34
0.93
3.8
4.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
18
119
1.58
0.93
1.8
1.5
—
—
—
0
0
(3019225) pH of Specimen
19
128
1.55
0.91
5.5
4.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
29
2.11
0.90
1.0
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
29
2.11
0.90
1.3
3.7
u/ml
13.1
41.5
—
6
29
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
42
1.95
0.90
2.5
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
76
657
1.30
0.88
7.1
5.3
estimate
0.0
0.0
0.00
14
117
(3009261) Glucose [Presence] in Urine by Test strip
77
667
1.30
0.87
5.7
3.9
estimate
0.0
0.0
0.00
15
112
(40760888) Immunoglobulin light chains.free panel - Serum
6
31
1.97
0.85
1.5
5.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
15
97
1.60
0.85
6.3
4.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
36
282
1.36
0.81
1.5
1.8
pmol/l
394.6
448.6
0.61
31
230
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
11
66
1.72
0.81
7.6
2.3
%
0.8
1.1
0.77
11
66
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
33
1.85
0.80
1.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
24
0.00
0.80
0.0
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
34
1.79
0.77
1.3
1.3
—
4.4
—
0
7
(3011397) Hemoglobin [Presence] in Urine by Test strip
39
313
1.33
0.75
4.8
3.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
24
313
0.72
0.71
2.9
4.6
%
14.2
21.1
—
8
159
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
51
429
1.28
0.70
2.3
3.2
ng/l
1502.5
1494.9
0.00
46
363
(3035350) Ketones [Presence] in Urine by Test strip
74
654
1.25
0.67
5.8
3.9
estimate
0.0
0.0
0.00
14
120
(3016879) Cocaine [Presence] in Urine
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
23
0.00
0.59
0.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
23
0.00
0.59
0.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
23
0.00
0.59
0.0
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
14
99
1.45
0.56
4.6
3.4
%
0.0
0.1
—
8
29
(4034850)
6
39
1.56
0.53
18.2
13.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
64
1.43
0.52
1.1
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
84
0.58
0.47
2.2
1.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
13
95
1.40
0.45
4.1
3.4
%
0.0
0.0
—
7
24
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
33
1.53
0.41
1.4
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
66
1.39
0.39
1.4
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
43
1.41
0.35
4.2
3.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
139
1350
1.26
0.35
40.5
17.7
umol/l
80.9
78.0
0.33
139
1350
(4010399)
7
96
0.72
0.32
1.0
1.4
—
—
—
0
0
(3020891) Body temperature
7
54
1.31
0.31
3.7
4.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
40
357
1.16
0.30
6.9
4.1
estimate
0.0
0.0
0.00
14
113
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
55
1.29
0.30
1.7
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
21
247
0.83
0.29
1.6
1.3
iu/ml
29.8
27.1
—
5
87
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
62
1.31
0.28
1.8
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
20
233
0.84
0.26
1.5
3.0
ug/l
0.4
0.8
—
9
163
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
114
1176
0.89
0.23
5.6
4.7
mu/l
2.1
3.0
0.45
102
1043
(1761482) Bacteria [#/volume] in Urine by Culture
5
40
1.26
0.22
11.0
4.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
40
1.26
0.22
1.6
1.9
—
—
—
0
0
(3013512) EKG study
38
416
0.89
0.22
5.2
4.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
42
1.20
0.21
2.4
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
42
1.20
0.21
1.0
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
11
0.00
0.21
0.0
2.3
—
8.3
—
0
11
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(4027681)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
12
100
1.22
0.18
10.4
3.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
38
350
1.11
0.18
5.6
3.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
121
0.81
0.18
1.5
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
27
298
0.89
0.18
6.9
4.2
kg/l
1.0
1.0
—
5
40
(3036481) Cortisol [Moles/volume] in Serum or Plasma
13
110
1.20
0.18
4.1
1.8
nmol/l
512.2
355.4
1.10
13
98
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
71
1.13
0.16
2.3
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
16
182
0.87
0.16
1.6
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
82
1.10
0.15
1.3
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
15
131
1.16
0.15
1.9
2.6
ug/l
5.1
5.1
—
10
119
(40760892) CBC W Ordered Manual Differential panel - Blood
30
276
1.11
0.15
6.4
5.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
24
262
0.90
0.13
1.2
1.2
u/ml
0.3
1.6
—
5
74
(40761511) CBC panel - Blood by Automated count
134
1322
1.09
0.10
29.3
13.7
—
—
—
0
0
(3000492) Spirometry study
13
116
1.13
0.09
1.5
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
45
431
1.06
0.09
4.9
3.6
mg/mmol
18.8
10.4
0.56
27
253
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
98
960
1.06
0.09
4.6
3.9
pmol/l
15.6
14.9
0.62
88
856
(3049717) Cytology report of Urine Cyto stain
6
57
1.05
0.08
1.0
3.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
7
64
1.10
0.08
1.1
1.3
u/ml
128.3
235.9
—
7
55
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
67
1.05
0.08
1.3
2.4
u/l
39.3
39.9
—
7
61
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
7
81
0.86
0.07
8.1
3.3
kpa
4.7
5.1
—
7
72
(36660697) Celiac disease serology panel - Serum
7
80
0.87
0.07
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
13
118
1.11
0.07
1.1
1.7
%
1.6
1.6
0.03
13
102
(3007164) IgA [Mass/volume] in Serum or Plasma
23
244
0.93
0.07
1.8
1.4
g/l
2.3
2.3
0.04
15
147
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
67
684
0.96
0.05
3.0
2.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
52
532
0.97
0.04
4.0
3.9
ng/l
225.2
33.1
0.58
37
388
(3007461) Platelets [#/volume] in Blood
140
1392
1.05
0.02
50.8
21.8
e9/l
247.6
248.0
0.02
135
1353
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
38
387
0.98
0.01
3.1
5.0
ug/l
1.3
2.4
1.29
30
344
(3022621) pH of Urine by Test strip
10
94
1.07
0.01
2.1
2.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
18
181
0.99
0.00
5.4
4.5
%
35.3
31.8
0.42
12
115
(3012516) Albumin [Mass/volume] in Urine
41
406
1.01
0.00
4.1
2.9
mg/l
124.9
221.2
0.24
25
252
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
50
505
0.99
0.00
6.7
4.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
165
1.03
0.00
12.6
8.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
11
115
0.95
0.00
8.4
3.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
11.2
—
0
5
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4024509)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
7
0.00
0.00
0.0
2.6
—
3.4
—
0
7
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
51
0.98
0.00
6.2
3.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
2.0
—
92.0
—
0
5
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
0.9
—
0
8
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
5
0.00
0.00
0.0
1.0
—
9.6
—
0
5
(3016244) Insulin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
13.9
—
0
6
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
1.2
—
0
5
(3020491) Glucose [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.6
—
7.7
—
0
8
(3029075) Extractable nuclear Ab panel - Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
6.5
—
0
5
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_ANUS_ANALCANAL – Malignant neoplasm of anus and anal canal
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).